Literature DB >> 6407250

Effect of dihydroergocristine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic, and acromegalic subjects: further evidence for pituitary dopamine deficiency in these conditions.

C Ferrari, M Romussi, R Benco, P Rampini, F Mailland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6407250     DOI： 10.1530/acta.0.1030001

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN： 0001-5598


× No keyword cloud information.
  3 in total

1.  Prolactin lowering effect of dihydroergokryptine in rat and in man.

Authors:  M Poli; D Cocchi; F Mailland; A M Masu; G Landi; A Craveri; E E Müller
Journal:  J Endocrinol Invest       Date:  1986-02       Impact factor: 4.256

Review 2.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

3.  Effect of dihydroergokryptine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic and acromegalic subjects: evidence of potent and long-lasting pituitary dopamine receptor stimulation.

Authors:  C Ferrari; P Rampini; A Paracchi; M Boghen; F Mailland
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.